Altamira Therapeutics Ltd. financial statements, including revenue, expenses, profit, and loss

The total revenue of CYTO for the last semiannual is 0.00 USD, and it's 100.00% lower compared to the previous semiannual. The net income of H1 24 is -4.34 M USD.